Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance
Health In Tech (Nasdaq: HIT) launched HitRix, an AI-powered platform to streamline large-group self-funded health insurance workflows. The company updated its 2026 revenue outlook to $33 million, in line with 2025. Growth is expected to accelerate in 2027 from HitRix, a Three-Year Rate Stabilization Program, and expanded carrier capacity.
How this was made

The 30-second read
Why it matters
The launch of HitRix aims to streamline broker workflows and could become a growth driver from 2027 onward, while the 2026 revenue guidance remains flat at $33M.
Market read
Primary news for HIT; modest impact on broader market, with potential longer-term sector relevance.
What to watch
Potential integration challenges and broker adoption rates could delay revenue benefits.
Background
Health In Tech (NASDAQ:HIT) is an AI-driven InsurTech platform targeting large-group self-funded health insurance markets.
Ticker impact
Health In Tech announced the HitRix platform launch and updated full-year 2026 revenue guidance to $33 million.
likely modest upside as market prices in product launch, but limited immediate impact
The revenue outlook remains flat, reducing upside; however, the AI platform launch could improve future earnings, creating slight positive pressure.
Market effects
May boost interest in AI-enabled InsurTech solutions across the health insurance sector.
Primarily U.S. market; limited immediate effect on broader regional indices.
Low global impact; relevance confined to niche InsurTech investors.
Counterpoint
Guidance unchanged suggests limited near-term upside; investors may wait for traction data before buying.
Key entities
- companyHealth In Tech, Inc.
AI-enabled InsurTech platform company launching HitRix.
- executiveTim Johnson
CEO of Health In Tech, quoted on HitRix launch.



